|
所属 |
大学院医学系研究科（保健学専攻） 理学療法学講座 |
職務経歴（学内） 【 表示 ／ 非表示 】
-
2023年04月-継続中
秋田大学 大学院医学系研究科（保健学専攻） 理学療法学講座 教授
-
2022年03月-2023年03月
秋田大学 大学院医学系研究科（医学専攻等） 医学専攻 機能展開医学系 整形外科学講座 准教授
-
2009年04月-2022年02月
秋田大学 附属病院 整形外科 講師
学位論文 【 表示 ／ 非表示 】
-
Surface strain distribution on thoracic and lumbar vertebrae under axial compression. The role in burst fractures
Hongo M, Abe E, Shimada Y, Murai H, Ishikawa N, Sato K
Spine 1998年03月
国内共著
研究等業績 【 表示 ／ 非表示 】
-
特集 エビデンスと実践知から探る 腰部脊柱管狭窄症診療の最適解 保存療法 腰部脊柱管狭窄症に対する運動療法-物理療法・装具療法を含めて
本郷 道生, 粕川 雄司, 宮腰 尚久
臨床整形外科 ( 株式会社医学書院 ) 61 ( 2 ) 139 - 143 2026年02月
-
Horikawa A.
Journal of Clinical Densitometry ( Journal of Clinical Densitometry ) 29 ( 1 ) 2026年01月
-
Cost-Effectiveness of Monotherapy versus Polypharmacy in Cervicobrachial Symptoms: A Nationwide Multicenter Analysis
Ito Sadayuki, Nakashima Hiroaki, Wakao Norimitsu, Furuya Takeo, Yoshii Toshitaka, Arima Hideyuki, Yamato Yu, Imagama Shiro, Imajo Yasuaki, Miyamoto Hiroshi, Inoue Gen, Miyagi Masayuki, Kanbara Shunsuke, Iizuka Yoichi, Chikuda Hirotaka, Watanabe Kei, Kobayashi Kazuyoshi, Tsushima Mikito, Miyazaki Masashi, Yagi Mitsuru, Suzuki Satoshi, Takahata Masahiko, Hongo Michio, Koda Masao, Nagata Keiji, Mori Kanji, Suzuki Akinobu, Kaito Takashi, Murotani Kenta, Miyakoshi Naohisa, Hashizume Hiroshi, Matsuyama Yukihiro, Kawakami Mamoru, Haro Hirotaka, The Project Committee of the Japanese Society for Spine Surgery and Related Research (JSSR)
Spine Surgery and Related Research ( 一般社団法人 日本脊椎脊髄病学会 ) advpub ( 0 ) 2026年
<p><b>Introduction: </b>Cervicobrachial symptoms are common causes of disability worldwide, yet the cost-effectiveness of combination therapy versus monotherapy remains unclear. In this nationwide multicenter study, we aimed to compare the economic value of multiple-drug therapy with that of monotherapy for cervicobrachial symptoms.</p><p><b>Methods: </b>This prospective observational study, conducted through the Japanese Society for Spine Surgery and Related Research, included 261 adults with cervicobrachial symptoms across 28 institutions (July 2020 to July 2022). Patients received monotherapy (n = 112) or multiple-drug therapy (n = 149) using five pre-specified agents: loxoprofen, celecoxib, acetaminophen, tramadol–acetaminophen, and pregabalin. The primary outcome was quality-adjusted life years (QALYs), calculated from monthly EuroQol 5-Dimension 5-Level assessments over six months. The secondary outcomes were drug costs and incremental cost-effectiveness ratios (ICERs), evaluated against Japan's reference threshold of ¥5,000,000 per QALY.</p><p><b>Results: </b>Mean QALY gains were similar between the monotherapy (0.00267 ± 0.00544) and multiple-drug therapy (0.00284 ± 0.00774) groups, with no statistically significant difference (p > 0.05). However, total drug costs were substantially higher with multiple-drug therapy (¥19,243 vs. ¥8,275). ICERs were more favorable for monotherapy (¥3,093,957/QALY) than for multiple-drug therapy (¥6,781,101/QALY). Among agents used as monotherapy, loxoprofen (¥744,409/QALY) and acetaminophen (¥781,293/QALY) showed the most favorable cost-effectiveness profiles, whereas tramadol–acetaminophen (¥6,370,451/QALY) and pregabalin (¥10,995,651/QALY) had the least favorable cost-effectiveness. Most QALY gains occurred during the first three months in both groups.</p><p><b>Conclusions: </b>Multiple-drug therapy approximately doubled pharmaceutical costs without providing additional QALY gains over six months. Monotherapy, particularly with non-steroidal anti-inflammatory drugs or acetaminophen, offers superior cost-effectiveness and should be prioritized as first-line treatment. These findings underscore the need for restraint in polypharmacy and provide real-world evidence to guide clinical decision-making and national healthcare policy.</p>
-
Kimura R.
Journal of Back and Musculoskeletal Rehabilitation ( Journal of Back and Musculoskeletal Rehabilitation ) 2026年
-
Ohtaka Maiko, Saito Akira, Hongo Michio, Matsuzaki Masashi
The Journal of Physical Fitness and Sports Medicine ( 一般社団法人日本体力医学会 ) advpub ( 0 ) 2026年
<p>This study aimed to evaluate a musculoskeletal screening method for elementary school students using ultrasound and lower limb flexibility assessments, with the goal of early detection of Osgood-Schlatter disease during the growth period. A total of 143 boys in the fourth to sixth grades of elementary school from a single prefecture underwent musculoskeletal screening between November 2021 and February 2023. Using a diagnostic ultrasound device, the tibial tuberosity was observed, and its developmental stage was classified based on Ehrenborg’s four-stage classification (Ehrenborg G and Lagergren C. 1961. <i>Acta Chir Scand</i> 121: 315–327). The presence of Osgood-Schlatter disease was determined based on the presence of irregularities in the ultrasound image. Lower limb flexibility was assessed quantitatively using finger-floor distance (FFD) and heel-hip distance (HHD). The cartilaginous stage (C stage) was the most common developmental stage observed. Osgood-Schlatter disease was identified in eight children (5.6%) and was found only in the epiphyseal (E) and bony (B) stages (<i>p</i> = 0.004, φ = 0.308). HHD was significantly greater in the Osgood-Schlatter group (<i>p</i> = 0.040, r = 0.680). In some children without knee pain or tenderness, irregularities in the tibial tuberosity were detected on ultrasound imaging, suggesting that ultrasound imaging may be useful for the early detection of asymptomatic lesions. This screening approach, which combines ultrasound examination and flexibility assessment, is expected to serve as a novel method for the early detection and prevention of musculoskeletal disorders in children during their growth period. Further large-scale studies and continued investigation into methods for assessing flexibility in growing children are warranted.</p>